Drug
Raloxifene
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Foot Deformity | 28 | 22.0 | 22.3 | signal |
| 2 | Body Height Decreased | 21 | 17.0 | 17.1 | signal |
| 3 | Nephropathy | 18 | 16.7 | 16.9 | signal |
| 4 | Hepatic Steatosis | 28 | 13.1 | 13.3 | signal |
| 5 | Osteonecrosis Of Jaw | 37 | 13.0 | 13.1 | signal |
| 6 | Ischaemic Stroke | 24 | 11.7 | 11.8 | signal |
| 7 | Joint Range Of Motion Decreased | 17 | 11.1 | 11.2 | signal |
| 8 | Synovitis | 21 | 10.1 | 10.2 | signal |
| 9 | Sciatica | 18 | 9.9 | 10.0 | signal |
| 10 | Osteoporosis | 39 | 8.3 | 8.4 | signal |
| 11 | Erythema Multiforme | 8 | 7.5 | 7.5 | signal |
| 12 | Cholelithiasis | 27 | 7.2 | 7.2 | signal |
| 13 | Bone Density Decreased | 26 | 7.2 | 7.2 | signal |
| 14 | Photosensitivity Reaction | 13 | 6.9 | 6.9 | signal |
| 15 | Limb Injury | 21 | 6.8 | 6.8 | signal |
| 16 | Movement Disorder | 25 | 6.8 | 6.8 | signal |
| 17 | Cardiomyopathy | 11 | 6.5 | 6.5 | signal |
| 18 | Femur Fracture | 23 | 6.5 | 6.5 | signal |
| 19 | Dysstasia | 21 | 6.2 | 6.3 | signal |
| 20 | Joint Stiffness | 17 | 5.6 | 5.7 | signal |
| 21 | Seasonal Allergy | 9 | 5.6 | 5.6 | signal |
| 22 | Osteoarthritis | 27 | 5.5 | 5.6 | signal |
| 23 | Fracture | 12 | 5.5 | 5.5 | signal |
| 24 | Dizziness Postural | 6 | 5.4 | 5.5 | signal |
| 25 | Macular Degeneration | 7 | 5.1 | 5.1 | signal |
| 26 | Rib Fracture | 12 | 5.1 | 5.1 | signal |
| 27 | Osteomyelitis | 10 | 4.8 | 4.8 | signal |
| 28 | Spinal Fracture | 11 | 4.8 | 4.8 | signal |
| 29 | Nerve Compression | 5 | 4.7 | 4.7 | signal |
| 30 | Skin Disorder | 18 | 4.7 | 4.7 | signal |
| 31 | Flatulence | 30 | 4.6 | 4.7 | signal |
| 32 | Psoriatic Arthropathy | 21 | 4.6 | 4.6 | signal |
| 33 | Rash Macular | 18 | 4.5 | 4.5 | signal |
| 34 | Hepatocellular Injury | 7 | 4.3 | 4.3 | signal |
| 35 | Musculoskeletal Pain | 26 | 4.3 | 4.3 | signal |
| 36 | Arthritis | 38 | 4.2 | 4.3 | signal |
| 37 | Infusion Site Pain | 6 | 4.1 | 4.1 | signal |
| 38 | Hip Fracture | 15 | 4.1 | 4.1 | signal |
| 39 | Breast Cancer Metastatic | 5 | 4.1 | 4.1 | signal |
| 40 | Laryngitis | 5 | 4.0 | 4.0 | signal |
| 41 | Ocular Discomfort | 5 | 4.0 | 4.0 | signal |
| 42 | Thyroid Disorder | 7 | 4.0 | 4.0 | signal |
| 43 | Impaired Driving Ability | 5 | 3.8 | 3.8 | signal |
| 44 | Dementia | 12 | 3.8 | 3.8 | signal |
| 45 | Eyelid Oedema | 5 | 3.7 | 3.7 | signal |
| 46 | Disease Recurrence | 20 | 3.7 | 3.7 | signal |
| 47 | Wrist Fracture | 5 | 3.6 | 3.6 | signal |
| 48 | Arthropathy | 23 | 3.6 | 3.6 | signal |
| 49 | Knee Operation | 4 | 3.6 | 3.6 | signal |
| 50 | Hot Flush | 30 | 3.5 | 3.5 | signal |
| 51 | Respiratory Tract Congestion | 6 | 3.3 | 3.3 | signal |
| 52 | Hair Texture Abnormal | 5 | 3.2 | 3.2 | signal |
| 53 | Serotonin Syndrome | 7 | 3.2 | 3.2 | signal |
| 54 | Tooth Disorder | 8 | 3.1 | 3.1 | signal |
| 55 | Sneezing | 8 | 3.1 | 3.1 | signal |
| 56 | Blindness Unilateral | 5 | 3.1 | 3.1 | signal |
| 57 | Product Packaging Issue | 3 | 2.8 | 2.8 | no signal |
| 58 | Eructation | 6 | 2.7 | 2.8 | signal |
| 59 | Psoriasis | 41 | 2.7 | 2.8 | signal |
| 60 | Drug Reaction With Eosinophilia And Systemic Symptoms | 8 | 2.7 | 2.7 | signal |
| 61 | Coeliac Disease | 3 | 2.7 | 2.7 | no signal |
| 62 | Malignant Melanoma | 4 | 2.6 | 2.6 | no signal |
| 63 | Full Blood Count Decreased | 6 | 2.6 | 2.6 | signal |
| 64 | Helicobacter Infection | 3 | 2.6 | 2.6 | no signal |
| 65 | Procedural Pain | 8 | 2.5 | 2.5 | signal |
| 66 | Product Odour Abnormal | 3 | 2.5 | 2.5 | no signal |
| 67 | Device Occlusion | 4 | 2.5 | 2.5 | no signal |
| 68 | Rebound Effect | 3 | 2.3 | 2.3 | no signal |
| 69 | Device Failure | 4 | 2.3 | 2.3 | no signal |
| 70 | Breast Cancer | 24 | 2.2 | 2.2 | signal |
| 71 | Product Substitution Issue | 14 | 2.1 | 2.1 | signal |
| 72 | Injection Site Irritation | 3 | 2.1 | 2.1 | no signal |
| 73 | Device Use Issue | 4 | 2.0 | 2.0 | no signal |
| 74 | Dysmenorrhoea | 3 | 2.0 | 2.0 | no signal |
| 75 | Osteonecrosis | 7 | 1.8 | 1.8 | no signal |
| 76 | Bone Loss | 3 | 1.7 | 1.7 | no signal |
| 77 | Exposure Via Skin Contact | 4 | 1.5 | 1.5 | no signal |
| 78 | Injection Site Mass | 6 | 1.4 | 1.4 | no signal |
| 79 | Dermatitis Atopic | 7 | 1.2 | 1.2 | no signal |
| 80 | Device Malfunction | 9 | 1.2 | 1.2 | no signal |
| 81 | Injection Site Urticaria | 3 | 1.1 | 1.1 | no signal |
| 82 | Device Use Error | 3 | 0.8 | 0.8 | no signal |
| 83 | Wrong Technique In Device Usage Process | 4 | 0.8 | 0.8 | no signal |
| 84 | Bladder Cancer | 4 | 0.6 | 0.6 | no signal |